Novo Nordisk CEO testifies at Senate over weight loss drug prices 24 SeptemberJohn Adams Novo Nordisk‘s top executive faces a Senate grilling on Tuesday over the high prices of the company’s weight loss drug Wegovy and diabetes [...]
